Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

Subjects:

Linear regression analysis results for the effect of log-transformed urinary BPA concentrations at two time points on serum thyroid concentrations at ages 10–12. by Jung Eun Choi (563339)

Subjects:

Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Subjects:

Estimated marginal means of the MF per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Subjects:

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

“…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…”

Effect of microencapsulated of lemongrass and mangosteen peel (MELM) level on gas kinetics and cumulative gas at 96 h after incubation. by Rittikeard Prachumchai (18771149)

Subjects:

Effect of cumulative gas during incubation durations of microencapsulated lemongrass and mangosteen peel (MELM) levels. by Rittikeard Prachumchai (18771149)

Subjects:

Effect of microencapsulated of lemongrass and mangosteen peel (MELM) level on microbial abundance. by Rittikeard Prachumchai (18771149)

Subjects:

Effect of microencapsulated of lemongrass and mangosteen peel (MELM) level on ruminal pH, ammonia-nitrogen (NH₃-N) concentration, methane production, and volatile fatty... by Rittikeard Prachumchai (18771149)

Subjects:

Effect of microencapsulated of lemongrass and mangosteen peel (MELM) level on <i>in vitro</i> digestibility of nutrients. by Rittikeard Prachumchai (18771149)

Subjects:

Ingredient and chemical composition of concentrate diet, rice straw, and microencapsulated of lemongrass and mangosteen peel (MELM) (%DM). by Rittikeard Prachumchai (18771149)

Subjects:

The total amount of gas produced by microencapsulated mangosteen peel and lemongrass (MELM) during the 0 to 96 hours of incubation. by Rittikeard Prachumchai (18771149)

Subjects:

Occurrence of species that increased and decreased across surveys. by Paul H. Zedler (2905520)